drugset / Trial / NCT00257283
Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
Phase 4
Completed
200 enrolled
Pronova BioPharma
Danish Heart Foundation · collabNorth Denmark Region · collabThe Danish Kidney Association · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this investigator initated study is to examine the effect of OMACOR (Omega-3-acid ethyl ester 90) on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis, who has previously experienced a cardiovascular event.
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lovaza | Other / unclassified | — | — |